
Keywords: AD; albumin dialysate; ALF; acute liver failure; BAL; bioartificial liver; ECT; extracorporeal therapy; ICP; intracranial pressure; RALF; recovery acute liver failure; ROS; reactive oxygen species; SRBAL; spheroid reservoir bioartificial liver; ST; standa